🇺🇸 FDA
Patent

US 10995328

Materials and methods for treatment of autosomal dominant cone-rod dystrophy

granted A61KA61K38/00A61K48/005

Quick answer

US patent 10995328 (Materials and methods for treatment of autosomal dominant cone-rod dystrophy) held by CRISPR THERAPEUTICS AG expires Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
CRISPR THERAPEUTICS AG
Grant date
Tue May 04 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00, A61K48/005